Esther Dillard: Access to Gene Therapy for Sickle Cell Disease
Esther Dillard, Anchor and Reporter for the Black Information Network at iHeartMedia, shared a post on LinkedIn:
“Gene therapy for sickle cell disease is one of the safest cures medicine has ever produced. A one-time treatment. Not a lifetime of transfusions and pain crises. A cure.
But access isn’t equal.
In this week’s episode of The Color Between the Lines, Dr. Haydar Frangoul explains why families in places like Alabama often have to travel hundreds of miles and wait months just to reach a center that can perform this treatment. That’s not an accident. That’s a choice, about where hospitals invest, who gets access to specialists, and which communities get left out of medical breakthroughs.
Full conversation this week.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning